A genotype-first approach to determine the translational impact of ABCA7 mutations in Alzheimer dementia Flanders Institute for Biotechnology
Enhancing the molecular understanding of complex, neurodegenerative brain diseases like Alzheimer’s disease, frontotemporal dementia, Parkinson’s disease and Lewy Body disorders and related diseases, neurogenetics with focus on early-onset and familial brain diseases, and translational research including biosampling, biobanking and databanking, as well as DNA screening and clinico-pathological characterization of mutation carriers.